COVID-19 Rapid Antibody Test Kits RayBiotech recently partnered with the NFL Alumni Association to supply COVID-19 rapid antibody test kits to retired NFL players, highlighting an opportunity to expand sales in the sports sector and leverage the current focus on health and safety.
Funding Grant for Research Receiving a $1 million grant for research in collaboration with OncoHost presents an opportunity for RayBiotech to further develop innovative products and solutions, potentially attracting new customers interested in cutting-edge proteomics technology.
2000 Target Antibody Array The launch of the 2000 target antibody array by RayBiotech provides an opportunity to showcase the benefits of high-density multiplexed technology in biomarker discovery, positioning the company as a leader in advanced research tools.
ELISA Test Technology Breakthrough The recent breakthrough in ELISA test technology by RayBiotech offers a unique selling point for sales representatives, allowing them to highlight the cutting-edge nature of the company's products and potentially attract customers seeking innovative solutions.
Revenue Potential With a revenue range of $10M - $50M, RayBiotech presents itself as a financially stable company with growth potential, making it an attractive partner for organizations looking for reliable suppliers in the biotechnology research industry.